GGrantIndex
← Leaderboards

John Langenfeld

Univ Of Med/Dent Nj-R W Johnson Med Sch

$3,679,743
Attributed
$3,679,743
Total exposure
2
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY201822
$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$3,679,743 · 2

By mechanism

R01$3,209,133 · 1
K22$470,610 · 1

Top collaborators

No co-investigators on record.

Most similar at Univ Of Med/Dent Nj-R W Johnson Med Sch

Same institution · by research overlap

Others in their field

Top investigators on “Bone Morphogenetic Proteins

Research focus

Bone Morphogenetic ProteinsAngiogenesisCancer CellCellsPharmaceutical ChemistryComputational BiologySignaling ProteinPharmaceutical PreparationsMalignant NeoplasmsLeadBiologyMetabolicReceptorMouse ModelMalignant Neoplasm Of LungMitochondriaPathway InteractionsCancer Cell LineCancer SurvivalDown-RegulationBone Morphogenetic Protein ReceptorsCrystallographyCancer TherapyCell Death

Grant awards (13)

Determining the mechanisms by which bone morphogenetic protein inhibition promotes survival/neurogenesis and to trigger AMPK hyperactivation that includes neuronal and cancer death cell$391,156
R01 · FY2022 · CA · contact PI
Developing bone morphogenetic receptor II inhibitors for the treatment of cancer$356,439
R01 · FY2022 · CA · contact PI
Developing bone morphogenetic receptor II inhibitors for the treatment of cancer$201,477
R01 · FY2022 · CA · contact PI
Targeting BMP type 2 receptor for the treatment of breast cancer.$63,172
R01 · FY2022 · CA · contact PI
Developing bone morphogenetic receptor II inhibitors for the treatment of cancer$363,713
R01 · FY2021 · CA · contact PI
Determining the effects of bone morphogenetic protein receptor 2 (BMPR2) inhibition on neural stem cell neurogenesis and regulation of energy homeostasis in Alzheimer’s disease and cancer$389,236
R01 · FY2020 · CA · contact PI
Developing bone morphogenetic receptor II inhibitors for the treatment of cancer$363,713
R01 · FY2020 · CA · contact PI
Developing bone morphogenetic receptor II inhibitors for the treatment of cancer$363,713
R01 · FY2019 · CA · contact PI
Developing bone morphogenetic receptor II inhibitors for the treatment of cancer$352,801
R01 · FY2019 · CA · contact PI
Developing bone morphogenetic receptor II inhibitors for the treatment of cancer$363,713
R01 · FY2018 · CA · contact PI
THE ROLE OF A BONE MORPHOGENETIC PROTEIN IN LUNG CANCER$156,870
K22 · FY2004 · CA
THE ROLE OF A BONE MORPHOGENETIC PROTEIN IN LUNG CANCER$156,870
K22 · FY2003 · CA
THE ROLE OF A BONE MORPHOGENETIC PROTEIN IN LUNG CANCER$156,870
K22 · FY2002 · CA